INDEGENE
|
The Current P/B Ratio of INDEGENE is 5.24.
Share Price | ₹571.3 | May 13,2025 |
Market Cap | ₹13,710.0 Cr | |
Book Value | ₹2,615.6 Cr | Mar2025 - Consolidated Results |
Price/Book | 5.24x | Calculated as MarketCap/Book Value |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PB (Price/Book ) ratio of INDEGENE
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹13,710.0 Cr] as on May 13,2025
(/) Book Value [ ₹2,615.6 Cr] based on Mar2025 - Consolidated Results
(=) P/B Ratio [ 5.24x ]
Thus, for INDEGENE , the investors are currently willing to pay '5.24 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of INDEGENE !
The chart below summarizes the trend in P/B Ratio of INDEGENE over the last five years.
Historical PB (Price/Book ) ratio chart of INDEGENE
PB Ratio Performance Analysis for INDEGENE
- INDEGENE 's p/b ratio for fiscal years ending Mar2024 to Mar2020 averaged 0.00x.
- INDEGENE 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, INDEGENE 's p/b ratio peaked in Mar2024 at 0x.
- INDEGENE 's p/b ratio hit its five-year low in Mar2024 of 0x.
How does INDEGENE 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
---|---|---|---|
INDEGENE | 2,615.60 | 5.24 | 13,710.0 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 63,666.80 | 6.41 | 407,971.0 |
DIVIS LABORATORIES LTD | 13,571.00 | 11.87 | 161,153.0 |
CIPLA LTD | 31,193.40 | 3.93 | 122,717.0 |
TORRENT PHARMACEUTICALS LTD | 6,856.15 | 15.96 | 109,392.0 |
DR REDDYS LABORATORIES LTD | 33,549.60 | 3.00 | 100,702.0 |
MANKIND PHARMA LTD | 9,339.84 | 11.26 | 105,125.0 |
ZYDUS LIFESCIENCES LTD | 19,829.50 | 4.58 | 90,727.1 |
LUPIN LTD | 14,175.80 | 6.65 | 94,200.0 |
AUROBINDO PHARMA LTD | 29,842.80 | 2.38 | 70,997.2 |
ABBOTT INDIA LTD | 3,658.73 | 17.67 | 64,648.9 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs INDEGENE 's P/B Ratio
Top 10 Industry Peers | PB Ratio |
---|---|
Min industry PB | 2.38x |
Max industry PB | 17.67x |
Median industry PB | 6.41x |
Average industry PB | 8.09x |
You may also like the below Video Courses